Mr. Craig Hebel serves as a Head of Operations for Lonza Houston, Inc. – Viral Based Therapeutics. Mr. Hebel served as a Vice President of Production of Vivante GMP Solutions, Inc. He has over 23 years experience in GMP biologics manufacturing. He served for Introgen Therapeutics as Director of Production Operations, and prior to that, he was employed by Tanox Biosystems (acquired by Genentech), which specialized in monoclonal antibody development. Mr. Hebel served as Director of Manufacturing of ThromboVision, Inc., a medical device company. He holds a BS degree in Zoology from Texas A&M University.